Gender difference of atorvastatin's vasoprotective effect in balloon-injured rat carotid arteries

European Journal of Pharmacology

Volumn 553, Issue 1-3, 2006, Pages 263-268

  Kurumazuka, Daisuke ^a   Mori, Tatsuhiko ^a   Matsumoto, Noriko ^a   Shirakawa, Hisashi ^a   Kimura, Sayaka ^a   Nakano, Daisuke ^a   Hayashi, Tetsuya ^a   Kitaura, Yasushi ^a   Matsumura, Yasuo ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Gender difference; NADPH dependent superoxide production; Statin; Vasoprotection

Indexed keywords

ATORVASTATIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; CAROTID ARTERY INJURY; CASTRATION; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; FEMALE; GONADECTOMY; MALE; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RAT; SEX DIFFERENCE;

ANIMALS; BALLOON DILATATION; CAROTID ARTERY INJURIES; FEMALE; HEPTANOIC ACIDS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; NADPH OXIDASE; ORCHIECTOMY; OVARIECTOMY; PYRROLES; RATS; RATS, SPRAGUE-DAWLEY; SEX CHARACTERISTICS; SUPEROXIDES;

EID: 33751207385     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.09.036     Document Type: Article

References (29)

1. Barrett-Connor E. Sex differences in coronary heart disease: why are women so superior? The 1995 Ancel Keys Lecture. Circulation 95 (1997) 252-264
2. Chen J., Zhang Z.G., Li Y., Wang Y., Wang L., Jiang H., Zhang C., Lu M., Katakowski M., Feldkamp C.S., and Chopp M. Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke. Ann. Neurol. 53 (2003) 743-751
3. Dobrzycka B., Dobrzycki S., Lenczewski A., Terlikowski S., and Kulikowski M. Effects of simvastatin only or in combination with continuous combined hormone replacement therapy on lipid levels in hypercholesterolemic women. Ginekol. Pol. 74 (2003) 937-942
4. Florian M., Freiman A., and Magder S. Treatment with 17-beta-estradiol reduces superoxide production in aorta of ovariectomized rats. Steroids 69 (2004) 779-787
5. Grady D., Rubin S.M., Petitti D.B., Fox C.S., Black D., Ettinger B., Ernster V.L., and Cummings S.R. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann. Intern. Med. 117 (1992) 1016-1037
6. Harrison D., Griendling K.K., Landmesser U., Hornig B., and Drexler H. Role of oxidative stress in atherosclerosis. Am. J. Cardiol. 91 (2003) 7A-11A
7. Herrington D.M., et al., for the HERS study group. Statin therapy, cardiovascular events, and total mortality in the Heart and Estrogen/Progestin Replacement Study (HERS). Circulation 105 (2002) 2962-2967
8. Hulley S., Grady D., Bush T., Furberg C., Herrington D., Riggs B., and Vittinghoff E. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 280 (1998) 605-613
9. Itoh S., Umemoto S., Hiromoto M., Toma Y., Tomochika Y., Aoyagi S., Tanaka M., Fujii T., and Matsuzaki M. Importance of NAD(P)H Oxidase-mediated oxidative stress and contractile type smooth muscle myosin heavy chain SM2 at the early stage of atherosclerosis. Circulation 105 (2002) 2288-2295
10. Jovanovic S., and Jovanovic A. Remodelling of guinea-pig aorta during pregnancy: selective alteration of endothelial cells. Hum. Reprod. 12 (1997) 2297-2302
11. Jovanovic S., and Jovanovic A. Pregnancy is associated with hypotrophy of carotid artery endothelial and smooth muscle cells. Hum. Reprod. 13 (1998) 1074-1078
12. Koh K.K., Cardillo C., Bui M.N., Hathaway L., Csako G., Waclawiw M.A., Panza J.A., and Cannon III R.O. Vascular effects of estrogen and cholesterol-lowering therapies in hypercholesterolemic postmenopausal women. Circulation 99 (1999) 354-360
13. Mendelsohn M.E., and Karas R.H. The protective effects of estrogen on the cardiovascular system. N. Engl. J. Med. 340 (1999) 1801-1811
14. Miller A.P., Chen Y.F., Xing D., Feng W., and Oparil S. Hormone replacement therapy and inflammation: interactions in cardiovascular disease. Hypertension 42 (2003) 657-663
15. Mori T., Durand J., Chen Y.-F., Thompson J.A., Bakir S., and Oparil S. Effects of short-term estrogen treatment on the neointimal response to balloon injury of rat carotid artery. Am. J. Cardiol. 85 (2000) 1276-1279
16. Mueck A.O., Seeger H., Deuringer F.U., and Wallwiener D. Effect of an estrogen/statin combination on biochemical markers of endothelial function in human coronary artery cell cultures. Menopause 8 (2001) 216-221
17. Mueck A.O., Seeger H., and Wallwiener D. Effect of statins combined with estradiol on the proliferation of human receptor-positive and receptor-negative breast cancer cells. Menopause 10 (2003) 332-336
18. Pu Q., Neves M.F., Virdis A., Touyz R.M., and Schiffrin E.L. Endothelin antagonism on aldosterone-induced oxidative stress and vascular remodeling. Hypertension 42 (2003) 49-55
19. Ranki H.J., Budas G.R., Crawford R.M., Davies A.M., and Jovanovic A. 17Beta-estradiol regulates expression of K (ATP) channels in heart-derived H9c2 cells. J. Am. Coll. Cardiol. 40 (2002) 367-374
20. Rossouw J.E., Anderson G.L., Prentice R.L., LaCroix A.Z., Kooperberg C., Stefanick M.L., Jackson R.D., Beresford S.A., Howard B.V., Johnson K.C., Kotchen J.M., Ockene J., and Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 288 (2002) 321-333
21. Schonbeck U., and Libby P. Inflammation, immunity, and HMG-CoA reductase inhibitors: statins as antiinflammatory agents?. Circulation 109 (2004) II-18-II-26
22. Seed M. The choice of hormone replacement therapy or statin therapy in the treatment of hyperlipidemic postmenopausal women. Atheroscler Suppl. 3 (2002) 53-63
23. Seeger H., Wallwiener D., and Mueck A.O. Additive antioxidative effect of hormone replacement therapy combined with a statin. Clin. Exp. Obstet. Gynecol. 27 (2000) 179-181
24. Shi Y., Niculescu R., Wang D., Patel S., Davenpeck K.L., and Zalewski A. Increased NAD(P)H oxidase and reactive oxygen species in coronary arteries after balloon injury. Arterioscler. Thromb. Vasc. Biol. 21 (2001) 739-745
25. Stampfer M.J., Colditz G.A., Willett W.C., Manson J.E., Rosner B., Speizer F.E., and Hennekens C.H. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study. N. Engl. J. Med. 325 (1991) 756-762
26. Taniyama Y., and Griendling K.K. Reactive oxygen species in the vasculature: molecular and cellular mechanisms. Hypertension 42 (2003) 1075-1081
27. Tolbert T., and Oparil S. Cardiovascular effects of estrogen. Am. J. Hypertens. 14 (2001) 186S-193S
28. Wassmann S., Laufs U., Baumer A.T., Muller K., Ahlbory K., Linz W., Itter G., Rosen R., Bohm M., and Nickenig G. HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species. Hypertension 37 (2001) 1450-1457
29. Zalba G., Beloqui O., Jose G.S., Moreno M.U., Fortuno A., and Diez J. NADPH oxidase-dependent superoxide production is associated with carotid intima-media thickness in subjects free of clinical atherosclerotic disease. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 1452-1457